MAPT and cancer: Between HER2 positive and negative groups, concentrations of Tau, s-Ins, and m-Ins of HER2 positive cancers were significantly higher than those of the HER2 negative cancers (p = 0.01, p = 0.03, and p = 0.01, respectively).